5 found
Order:
  1.  16
    Governance of Emerging Biotechnologies: Lessons from Two Chinese Cases.Yuming Wang, Zhenxiang Zhang, Yubao Wei, Yongguang Yang, Jing Wang, Cuilian Zhang & Hui Zhang - 2022 - American Journal of Bioethics 22 (1):56-58.
    Ankeny et al. focuses on the recent creation of “iBlastoids” and defends the need for reflexive, anticipatory, and deliberative approaches in the domain of emerging and potentially contentio...
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  2.  18
    Contingency Measures During the COVID-19 Pandemic in China: An Analysis Based on a New Ethical Framework.Zhiping Guo, Zhenxiang Zhang, Yongguang Yang, Hui Zhang & Yuming Wang - 2021 - American Journal of Bioethics 21 (8):28-30.
    The target article by David Alfandre et al. offers a new ethical framework to guide COVID-19 contingency surge planning and response, and applies this ethical framework to three case example...
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  3.  24
    Instruments of Moral Distress: An Analysis Based on Scientificity and Application Value.Lijun Shen, Hui Zhang, Yongguang Yang, Shixiu Liao & Yuming Wang - 2023 - American Journal of Bioethics 23 (4):89-91.
    In the target article by Kolbe and de Melo-Martin (2023), the authors discussed several shortcomings of major instruments of moral distress, including the Moral Distress Scale (MDS) (Corley et al....
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  4.  19
    Assisted Dying: More Attention Should Be Paid to the Epistemic Asset of Personal Experience.Yuming Wang, Yongguang Yang, Feifei Gao, Lihan Miao & Hui Zhang - 2023 - American Journal of Bioethics 23 (1):46-49.
    The target article (Nelson et al. 2023) offers a valuable contribution to the “paradox of experience,” which was illustrated by using examples about access to unproven medical products and disabili...
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  5.  18
    What Can We Learn from COVID-19 Drug Development and Access for Non-Pandemic Diseases? A Chinese Perspective.Hui Zhang, Zhiping Guo, Lijun Shen, Yongguang Yang, Zhenxiang Zhang & Yuming Wang - 2021 - American Journal of Bioethics 21 (12):42-45.
    The target article by Lynch et al. offers approaches for improving trial availability and Expanded Access for non-pandemic diseases based on the analysis of the COVID-19 experience in the US...
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark